
11 - 50 employés
Fondée en 2013
🏥 Santé
💊 Pharmaceutique
💰 €55 000 000 Series D en 2021-08
Healthcare • Pharmaceuticals
ARS Pharmaceuticals, Inc. est une entreprise pharmaceutique engagée dans le développement de traitements conviviaux pour les patients, afin de répondre aux problèmes sérieux liés aux risques associés aux aiguilles et à la facilité d'utilisation des dispositifs. L'entreprise a introduit 'neffy', le premier et le seul spray nasal à l'épinéphrine sans aiguille approuvé par la FDA, offrant une méthode d'administration alternative pour l'épinéphrine, facile à transporter et à administrer. ARS Pharma vise à rendre ces traitements accessibles et abordables grâce à des programmes d'économies et de soutien. La société est axée sur des thérapies innovantes qui autonomisent les patients et les soignants, s'efforçant de proposer des options pratiques pour l'administration de l'épinéphrine.
🕒 il y a 2 mois
🇺🇸 États-Unis – Télétravail
💵 $325 000 - $400 000 / an
⏰ Temps Plein
🔴 Expert
👔 Vice-président
👻 Score fantôme 4%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de ARS Pharmaceuticals, Inc. ↗, pas via un site d'emploi
Repérée par Remote Rocketship il y a 2 mois
Toujours ouverte sur le site de ARS Pharmaceuticals, Inc.. Vérifiée il y a 7 heures.

11 - 50 employés
Fondée en 2013
🏥 Santé
💊 Pharmaceutique
💰 €55 000 000 Series D en 2021-08
Healthcare • Pharmaceuticals
ARS Pharmaceuticals, Inc. est une entreprise pharmaceutique engagée dans le développement de traitements conviviaux pour les patients, afin de répondre aux problèmes sérieux liés aux risques associés aux aiguilles et à la facilité d'utilisation des dispositifs. L'entreprise a introduit 'neffy', le premier et le seul spray nasal à l'épinéphrine sans aiguille approuvé par la FDA, offrant une méthode d'administration alternative pour l'épinéphrine, facile à transporter et à administrer. ARS Pharma vise à rendre ces traitements accessibles et abordables grâce à des programmes d'économies et de soutien. La société est axée sur des thérapies innovantes qui autonomisent les patients et les soignants, s'efforçant de proposer des options pratiques pour l'administration de l'épinéphrine.
• Own clinical strategy and execution for ARS Pharma’s allergy and urticaria portfolio • Lead clinical development programs from IND-enabling studies through Phase 3 registration trials • Lead trial design across study populations, endpoints, comparators, and statistical approaches • Translate medical and evidence strategy into clinical development plans, study designs, timelines, and risk/benefit tradeoffs • Author and oversee clinical protocols, investigator brochures, statistical analysis plans, clinical study reports, and other core clinical documents • Represent clinical development in interactions with FDA, EMA, and other health authorities • Provide medical monitoring oversight and clinical data interpretation • Partner with Clinical Operations and CROs to execute trials on time, on budget, and to GCP/ICH standards • Oversee site selection, enrollment strategy, and vendor management • Chair or co-chair internal safety review committees and support benefit-risk decisions and post-market clinical surveillance • Contribute clinical development expertise to pipeline expansion and business development opportunities • Partner with Medical Affairs and HEOR/RWE colleagues to generate evidence supporting adoption, guideline inclusion, and payer/reimbursement narratives • Engage key opinion leaders, investigators, and scientific advisory boards to inform trial design and endpoint selection • Represent clinical development in board meetings, investor updates, and partner/licensing discussions • Build, lead, and mentor a growing clinical development team
• MD, MD/PhD, or PharmD required • 12+ years of progressive clinical development leadership in the biotechnology or pharmaceutical industry • Significant hands-on clinical development experience in allergy, urticaria (including chronic spontaneous urticaria), or related immunology-mediated therapeutic areas • Demonstrated success leading clinical programs from IND through registration (BLA/NDA), including direct authorship of protocols and regulatory submissions • Executive presence and ability to partner effectively with the C-Suite and cross-functional leaders across Regulatory, Biometrics, Clinical Operations, Pharmacovigilance, and Commercial in a publicly traded environment • U.S.-based • Ability to travel domestically and internationally for key internal and partner meetings (up to 20–30%) • Experience presenting clinical data and development strategy to regulatory agencies, scientific advisory boards, and investigator/KOL audiences • Experience advising executive leadership on clinical development strategy, trial design, and risk/benefit tradeoffs • In-depth knowledge of allergy and urticaria therapeutic areas • Current knowledge of FDA, EMA, and global regulatory landscapes • Expertise in clinical trial design, including study populations, endpoint selection, comparator strategy, and adaptive/innovative trial methodologies • Experience managing global, multi-site clinical trials, including work with CROs and central labs • Ability to operate effectively in a hands-on, fast-paced environment with limited infrastructure and evolving organizational needs
• Performance-based incentive compensation eligibility • Equity • 401k matching • 100% employer-paid medical insurance for employees • 100% employer-paid dental insurance for employees • 100% employer-paid vision insurance for employees • Reasonable accommodation for qualified individuals with disabilities
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 2 mois
Healthcare executive leading Centene's ICHRA provider network strategy and value-based contracting. Building multi-market provider networks and managing negotiations, performance, budgets, and governance.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Vice President of Accounting leading accounting, reconciliation, and money movement operations for PayNearMe’s enterprise payments platform. Ensuring accurate client-funds flows, controls, and GAAP-compliant reporting at scale.
🇺🇸 États-Unis – Télétravail
💵 $275 000 - $325 000 / an
🔥 Financement dans la dernière année
💰 €50 000 000 Series E - PayNearMe en 2025-09
⏰ Temps Plein
🔴 Expert
👔 Vice-président
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Vice President of FP&A modernizing planning, forecasting, and analytics for Saviynt’s AI-powered identity security platform. Leading a 25-person finance team and scaling SaaS financial operations.
🇺🇸 États-Unis – Télétravail
💰 €130 000 000 Private Equity Round en 2021-09
⏰ Temps Plein
🔴 Expert
👔 Vice-président
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
VP of Finance leading FP&A, IPO readiness, and capital planning at Sidecar Health. Shaping financial strategy for a mission-driven U.S. health insurance company.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Vice President leading Med-Metrix’s hospital revenue-cycle denials prevention transformation. Driving analytics, payer strategies, and operational change to protect revenue and improve clean-claim performance.
🗣️🇺🇸🇬🇧 Anglais requis